Leaders in Healthcare 2017: a reflection A canter through this year’s conference prompts reflection on both the foundation and direction of the leadership agenda The Leaders in Healthcare conference aims to “improve outcomes for patients and communities, provide practical ideas that can be implemented in healthcare, promote research into high quality leadership and management, foster […]
Category: Editors at large
Anya de Iongh: Making patient co-production meaningful and impactful
Last week saw the annual meeting of The BMJ’s Patient Panel—an international meeting across at least four continents via plane, car, train, and phone to discuss The BMJ’s partnership with patients. Since 2014, the panel has brought together international patients, advocates, and leaders in the field of people’s (patients or carers) experience, involvement, engagement, and […]
Robert Mugabe is an improbable Goodwill Ambassador for Health
WHO have cancelled Mugabe’s goodwill ambassador role, but this was an uncharacteristic misstep by the WHO DG […]
Robin Baddeley: Fixing the broken medical ward round is in everyone’s interests
Giving doctors time, space, and continuity may actually save money […]
Niamh Brooks: Celebrating women in medicine—a 150 year journey
To have made female clinicians the norm is an accomplishment worth celebrating […]
Will Stahl-Timmins: Can graphic design save your life?
An exhibition of beautiful and significant design work, which asks the wrong question of the wrong people, writes Will Stahl-Timmins […]
Partnership between the BMJ and Pfizer: Learn and change to improve the evidence
People do health research for many different reasons. Most, we hope, try to answer questions that are important to patient care or policy, with a chance of informing service development or improving health. This is particularly urgent in lower income countries, where there is still not nearly enough locally derived evidence to drive and support […]
Robin Baddeley: Should UK training programmes have doctors based on one site for two years?
A “residency model” may help rebuild bonds between doctors and their employers […]
Peter Doshi: Speed vs safety in the FDA’s new drug approvals—speed wins, again
In the late 1980s, AIDS activists stormed the headquarters of the US Food and Drug Administration (FDA) with a message that the FDA’s drug approval process was, simply put, killing people by blocking the approval of new treatments. One protester’s shirt read: “If I die of AIDS—forget burial—just drop my body on the steps of […]
Theo Bloom: Transparency or anonymity in peer review—which is fairer?
Increasing openness is a better route to eliminating biases than increasing anonymity […]